ARS Pharmaceuticals (SPRY)

• Market cap: $1.15B
• 1 day: 0.09%
• 5 days: 5.05%
• 1 month: 23.94%
• 3 months: 15.92%
• 6 months: -33.24%
• Year to date: 8.78%
• 1 year: 10.43%
• 5 years: -74.86%
• 10 years: -53.4%
• Sector: Healthcare
• Industry: Biotechnology

About: ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Employees: 167